These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32568624)

  • 1. Emerging importance of molecular pathogenesis of vascular malformations in clinical practice and classifications.
    Pang C; Lim CS; Brookes J; Tsui J; Hamilton G
    Vasc Med; 2020 Aug; 25(4):364-377. PubMed ID: 32568624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular changes associated with vascular malformations.
    Fereydooni A; Dardik A; Nassiri N
    J Vasc Surg; 2019 Jul; 70(1):314-326.e1. PubMed ID: 30922748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Basis and Therapies for Vascular Anomalies.
    Queisser A; Seront E; Boon LM; Vikkula M
    Circ Res; 2021 Jun; 129(1):155-173. PubMed ID: 34166070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated TGF-β/BMP Signaling in Vascular Malformations.
    Cunha SI; Magnusson PU; Dejana E; Lampugnani MG
    Circ Res; 2017 Sep; 121(8):981-999. PubMed ID: 28963191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of vascular malformation and therapeutic implications.
    Zúñiga-Castillo M; Teng CL; Teng JMC
    Curr Opin Pediatr; 2019 Aug; 31(4):498-508. PubMed ID: 31246627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular and Lymphatic Malformations: Perspectives From Human and Vertebrate Studies.
    Janardhan HP; Saheera S; Jung R; Trivedi CM
    Circ Res; 2021 Jun; 129(1):131-135. PubMed ID: 34166069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of vascular birthmarks.
    Mahajan P; Bergstrom KL; Phung TL; Metry DW
    Clin Dermatol; 2022; 40(4):313-321. PubMed ID: 35181412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ISSVA Classification of Vascular Anomalies and Molecular Biology.
    Kunimoto K; Yamamoto Y; Jinnin M
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Causes of Vascular Malformations and Common Signaling Pathways Involved in Their Formation.
    Rose AL; Cathey SS
    Dermatol Clin; 2022 Oct; 40(4):449-459. PubMed ID: 36243432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the endothelial pathogenic mechanism of TIE2-related venous malformation.
    Du Z; Zheng J; Zhang Z; Wang Y
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):740-748. PubMed ID: 28818232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD10 and CD34 as markers in vascular malformations with PIK3CA and TEK mutations.
    Moneghini L; Tosi D; Graziani D; Caretti A; Colletti G; Baraldini V; Cattaneo E; Spaccini L; Zocca A; Bulfamante GP
    Hum Pathol; 2020 May; 99():98-106. PubMed ID: 32272124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations.
    Ye C; Pan L; Huang Y; Ye R; Han A; Li S; Li X; Wang S
    J Vasc Surg; 2011 Dec; 54(6):1760-8. PubMed ID: 21962923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A xenograft model for venous malformation.
    Goines J; Li X; Cai Y; Mobberley-Schuman P; Metcalf M; Fishman SJ; Adams DM; Hammill AM; Boscolo E
    Angiogenesis; 2018 Nov; 21(4):725-735. PubMed ID: 29786783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How we approach the use of sirolimus and new agents: Medical therapy to treat vascular anomalies.
    Shimano KA; Eng W; Adams DM
    Pediatr Blood Cancer; 2022 Aug; 69 Suppl 3():e29603. PubMed ID: 35253343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classification of vascular tumors and malformations: basis for classification and clinical purpose].
    Moure C; Reynaert G; Lehmman P; Testelin S; Devauchelle B
    Rev Stomatol Chir Maxillofac; 2007 Jun; 108(3):201-9. PubMed ID: 17532354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations.
    di Blasio L; Puliafito A; Gagliardi PA; Comunanza V; Somale D; Chiaverina G; Bussolino F; Primo L
    Cell Death Dis; 2018 Jan; 9(2):45. PubMed ID: 29352118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss-of-Function Mutations in ELMO2 Cause Intraosseous Vascular Malformation by Impeding RAC1 Signaling.
    Cetinkaya A; Xiong JR; Vargel İ; Kösemehmetoğlu K; Canter Hİ; Gerdan ÖF; Longo N; Alzahrani A; Camps MP; Taskiran EZ; Laupheimer S; Botto LD; Paramalingam E; Gormez Z; Uz E; Yuksel B; Ruacan Ş; Sağıroğlu MŞ; Takahashi T; Reversade B; Akarsu NA
    Am J Hum Genet; 2016 Aug; 99(2):299-317. PubMed ID: 27476657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perspectives on molecular diagnosis and targeted therapy for complex vascular malformations in pediatrics].
    Zhang B; He R; Song L; Ma L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Sep; 57(9):1481-1488. PubMed ID: 37743312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular tumours and malformations, classification, pathology and imaging].
    Wassef M; Vanwijck R; Clapuyt P; Boon L; Magalon G
    Ann Chir Plast Esthet; 2006; 51(4-5):263-81. PubMed ID: 17005309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.